Micro-Cap Liquidity Crunch Contrasts with Semi-Equip Boom in 2026 Mixed Equities CheckGlobal Report·1 day ago, 04:13 AMCOHU-11.17%AUPH-1.71%
Aurinia Pharmaceuticals (AUPH) Launches PRESERVE Study, Is A 5% Undervalued View Enough?Simplywall·Jul 8 at 02:59 AMAUPH-1.71%
TD Cowen Reaffirms Their Buy Rating on Aurinia Pharmaceuticals (AUPH)Tip Ranks·Jul 6 at 02:35 PMAUPH-1.71%
Aurinia Pharmaceuticals posts corporate presentation on LUPKYNIS growth, autoimmune disease pipeline focusPUBT·Jul 6 at 07:15 AMAUPH-1.71%
Aurinia’s PRESERVE Trial: New Combination Strategy for Lupus Nephritis in FocusTip Ranks·Jun 12 at 11:34 AMAUPH-1.71%GSK+3.33%
Aurinia Pharmaceuticals' (AUPH) CEO Bought 815,000 Shares for $12.5 Millionnasdaq·Jun 7 at 07:30 AMAUPH-1.71%
10 Health Care Stocks Whale Activity In Today's Sessionbenzinga_article·Jun 5 at 12:35 PMVEEV+3.47%UNH+2.67%
Chief Executive Officer Of Aurinia Pharmaceuticals Makes $12.46M Buybenzinga_article·Jun 3 at 10:01 AMAUPH-1.71%
Aurinia Pharmaceuticals Completes Acquisition of Kezar Life SciencesTip Ranks·May 11 at 08:59 AMAUPH-1.71%KZR0.00%
